UBS Group
NUVA

UBS Group’s NuVasive, Inc. NUVA Stock Holding History

UBS Group’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,200
Closed -$1.01M – 8182
2017
Q3 		$1.01M Buy
+18,200
New +$1.2M ﹤0.01% 3699
2015
Q2 		– Sell
-200
Closed -$9K – 8942
2015
Q1 		$9K Buy
+200
New +$9.29K ﹤0.01% 7744

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

UBS Group's NUVA Position: Q3 2023 in Review

UBS Group sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 4,740 shares — an estimated $197K sold.

UBS Group first reported a position in NUVA in Q4 2014 and held it in 35 quarters. The position peaked at $61M in Q1 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • UBS Group reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 4,740 NuVasive, Inc. shares in Q3 2023, an estimated $197K.
  • UBS Group first reported a position in NuVasive, Inc. in Q4 2014 and held it in 35 quarters.
  • UBS Group's NuVasive, Inc. position peaked at $61M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.